T cell receptor alpha variable 11 (TRAV11)

T cell receptor alpha variable 11 (TRAV11) encodes the variable region of the alpha chain of the T cell receptor (TCR), which is responsible for antigen recognition in T lymphocytes. The TCR is a heterodimeric protein complex (usually composed of alpha and beta chains) on the surface of T cells that recognizes peptide antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells[1][2][3]. The variable (V) regions of both the alpha and beta chains determine the antigen specificity of the T cell, with diversity generated through V(D)J recombination during T cell development[1][2]. TRAV11 is one of many variable alpha gene segments contributing to the diversity of the TCR repertoire. TCR engagement initiates signal transduction cascades resulting in T cell activation, proliferation, and differentiation, and plays a central role in adaptive immunity and immune surveillance against pathogens and tumors[2][3]. Alterations in TCR specificity or signaling (including specific variable region usage such as TRAV11) have implications in infection, cancer, and autoimmune diseases. Although TRAV11 itself is not a unique drug target, modulation of TCR complex function underpins many immunotherapies and immunosuppressive strategies[2][3].

Other names

TCRAV11S1TRAV11

Immunosuppressive agents act by inhibiting TCR-mediated T cell activation (e.g., calcineurin inhibitors block downstream signaling from TCR-CD3 complex)[2][3]. Checkpoint inhibitors modulate downstream signaling pathways of TCR activation.